A new era of weight loss medication began on Wednesday: The Food and Drug Administration has approved Eli Lillys GLP-1 oral pill for sale in the United States
For instance, individuals with Class 3 obesity were 2.1 times more likely to receive a first-time T2D diagnosis and 3.2 times more likely to receive a sleep apnea diagnosis compared to those with overweight
Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R et al
News articles abound about the fears around high prices for GLP-1s, and Senators are claiming the prices are unjustifiably high because of how many patients could benefit from them if they were cheaper
doi: 10.1371/journal.pbio.2001959 133 WangHZhouMBrandJHuangL
Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity